In Pedigree 1, the proband (III-6) was a 40-year-old woman who came to the Hangzhou First People’s Hospital for the regular treatment of T2DM; she was administrated with metformin and insulin therapy (0.4 μ/kg). The gene discussed is INS; the disease is type 2 diabetes mellitus.